We provide clients with services throughout the entire lifecycle of new drugs, including clinical development strategies, feasibility investigations, enrollment strategies, KOL consultations.
Clinical Development Plan (CDP), Pipeline analysis
Clinical development feasibility investigations, Regulatory and guideline analysis
Research sites investigations and enrollment strategy analysis
Clinical expert recommendation and consultation